# Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers

> **NCT01043094** · PHASE4 · COMPLETED · sponsor: **Kowa Research Institute, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Severe Renal Impairment

## Interventions

- **DRUG:** Pitavastatin 4mg

## Key facts

- **NCT ID:** NCT01043094
- **Lead sponsor:** Kowa Research Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-04
- **Final completion:** 2010-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01043094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01043094, "Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT01043094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*